Search

Author/Creator Yang, Huyuan

1. A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end‐stage renal disease requiring haemodialysis. (16th May 2016)

Authors:
Gupta, Neeraj; Hanley, Michael J.; Harvey, R. Donald; Badros, Ashraf; Lipe, Brea; Kukreti, Vishal; Berdeja, Jesus; Yang, Huyuan; Hui, Ai‐Min; Qian, Mark; Zhang, Xiaoquan; Venkatakrishnan, Karthik; Chari, Ajai
Journal:
British journal of haematology
Issue:
Volume 174:Number 5(2016)
Page Start:
748
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma. (January 2019)

Authors:
Dimopoulos, Meletios A.; Grosicki, Sebastian; Jędrzejczak, Wiesław W.; Nahi, Hareth; Gruber, Astrid; Hansson, Markus; Gupta, Neeraj; Byrne, Catriona; Labotka, Richard; Teng, Zhaoyang; Yang, Huyuan; Grzasko, Norbert; Kumar, Shaji
Journal:
European journal of cancer
Issue:
Volume 106(2019)
Page Start:
89
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Corrigendum: Exposure—efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease. (29th January 2018)

Authors:
Rosario, Maria; French, Jonathan L; Dirks, Nathanael L; Sankoh, Serap; Parikh, Asit; Yang, Huyuan; Danese, Silvio; Colombel, Jean-Frédéric; Smyth, Michael; Sandborn, William J; Feagan, Brian G; Reinisch, Walter; Sands, Bruce E; Sans, Miguel; Fox, Irving
Journal:
Journal of Crohn's and colitis
Issue:
Volume 12:Number 4(2018:Apr.)
Page Start:
510
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Exposure–efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease. (17th February 2017)

Authors:
Rosario, Maria; French, Jonathan L; Dirks, Nathanael L; Sankoh, Serap; Parikh, Asit; Yang, Huyuan; Danese, Silvio; Colombel, Jean-Frédéric; Smyth, Michael; Sandborn, William J; Feagan, Brian G; Reinisch, Walter; Sands, Bruce E; Sans, Miguel; Fox, Irving
Journal:
Journal of Crohn's and colitis
Issue:
Volume 11:Number 8(2017:Aug.)
Page Start:
921
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Fecal Calprotectin Responses Following Induction Therapy With Vedolizumab in Moderate to Severe Ulcerative Colitis: A Post Hoc Analysis of GEMINI 1. Issue 4 (14th March 2019)

Authors:
Reinisch, Walter; Bressler, Brian; Curtis, Rebecca; Parikh, Asit; Yang, Huyuan; Rosario, Maria; Røseth, Arne; Danese, Silvio; Feagan, Brian; Sands, Bruce E; Ginsburg, Philip; Dassopoulos, Themistocles; Lewis, James; Xu, Jing; Wyant, Tim
Journal:
Inflammatory bowel diseases
Issue:
Volume 25:Issue 4(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Fecal Calprotectin Responses Following Induction Therapy With Vedolizumab in Moderate to Severe Ulcerative Colitis: A Post Hoc Analysis of GEMINI 1. Issue 4 (5th October 2018)

Authors:
Reinisch, Walter; Bressler, Brian; Curtis, Rebecca; Parikh, Asit; Yang, Huyuan; Rosario, Maria; Røseth, Arne; Danese, Silvio; Feagan, Brian; Sands, Bruce E; Ginsburg, Philip; Dassopoulos, Themistocles; Lewis, James; Xu, Jing; Wyant, Tim
Journal:
Inflammatory bowel diseases
Issue:
Volume 25:Issue 4(2019)
Page Start:
803
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Model‐Informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor. Issue 2 (23rd March 2018)

Authors:
Gupta, Neeraj; Hanley, Michael J.; Diderichsen, Paul M.; Yang, Huyuan; Ke, Alice; Teng, Zhaoyang; Labotka, Richard; Berg, Deborah; Patel, Chirag; Liu, Guohui; van de Velde, Helgi; Venkatakrishnan, Karthik
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 105:Issue 2(2019)
Page Start:
376
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Pharmacokinetics of ixazomib, an oral proteasome inhibitor, in solid tumour patients with moderate or severe hepatic impairment. (29th May 2016)

Authors:
Gupta, Neeraj; Hanley, Michael J.; Venkatakrishnan, Karthik; Perez, Raymond; Norris, Robin E.; Nemunaitis, John; Yang, Huyuan; Qian, Mark G.; Falchook, Gerald; Labotka, Richard; Fu, Siqing
Journal:
British journal of clinical pharmacology
Issue:
Volume 82:Number 3(2016:Sep.)
Page Start:
728
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗